Search - tctmd.com

Displaying 1 - 20 of 33

Sort: Relevancy | Date

News Conference News ESC 2025

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

Michael O'Riordan

September 10, 2025

News Daily News

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

L.A. McKeown

June 17, 2025

Podcast TCTMD Talking Points

The PROACT Trial

March 05, 2025

News Daily News

Top Heart Failure News of 2024

Todd Neale

December 31, 2024

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2024

Shelley Wood

December 03, 2024

Presentation AHA 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

Presenter: Marcely Gimenes Bonatto

November 18, 2024

News Conference News AHA 2024

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

Caitlin E. Cox

November 18, 2024

News Conference News AHA 2024

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Shelley Wood

November 14, 2024

News Daily News

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Caitlin E. Cox

October 24, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Opinion Editor's Corner ACC 2024

What’s Going to Be Hot at ACC 2024

Shelley Wood

April 01, 2024

News Daily News

Pediatric Patients With Advanced Heart Disease Want to Be Heard

Caitlin E. Cox

May 15, 2023

News Daily News

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

Caitlin E. Cox

April 26, 2023

News Daily News

CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors

Yael L. Maxwell

April 13, 2023

News Daily News

More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints

L.A. McKeown

April 06, 2023

News Daily News

TCTMD’s Top 10 Most Popular Stories for March 2023

Shelley Wood

March 30, 2023

News Conference News ACC 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

L.A. McKeown

March 04, 2023

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

Advertisement

ESC/EAS Stress Early LDL-Lowering in Select High-risk Patients

CV Risk Modest for Most Cancer Survivors in Large Danish Registry

The PROACT Trial

Top Heart Failure News of 2024

TCTMD’s Top 10 Most Popular Stories for November 2024

Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial

ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH

One Hundred Years and Beyond: What's Going to Be Hot at AHA 2024

Heart Failure and Cancer: HFSA Statement Explores the Interplay

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

What’s Going to Be Hot at ACC 2024

Pediatric Patients With Advanced Heart Disease Want to Be Heard

Breast Cancer Deaths Lower With Statin Therapy, Taiwanese Data Hint

CV Risk Disparities by Race/Ethnicity Persist in Childhood Cancer Survivors

More AF Surveillance Needed in Chemotherapy Trials, Meta-analysis Hints

TCTMD’s Top 10 Most Popular Stories for March 2023

STOP-CA: Atorvastatin Curbs Heart Function Decline During Chemotherapy

What’s Going to Be Hot at ACC/WCC 2023?

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content